The new findings, from the Minimally Invasive Technology Role and Evaluation (MITRE) study, were presented at the American Diabetes Association 67th Scientific Sessions, in Chicago, Illinois.

• 这项来自微创科技角色与评估（MITRE）研究的数据，发表在伊利诺州芝加哥美国糖尿病医学会第67届科学座谈会上。